These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Issues surrounding therapeutic choices for hemophilia patients. Van den Berg HM Haematologica; 2004 Jun; 89(6):645-50. PubMed ID: 15194529 [No Abstract] [Full Text] [Related]
23. The Evolution of Hemophilia Care: Clinical and Laboratory Advances, Opportunities, and Challenges. Trinchero A; Sholzberg M; Matino D Hamostaseologie; 2020 Aug; 40(3):311-321. PubMed ID: 32726826 [TBL] [Abstract][Full Text] [Related]
24. The management of hemophilia patients with inhibitors. Nilsson IM Transfus Med Rev; 1992 Oct; 6(4):285-93. PubMed ID: 1421831 [No Abstract] [Full Text] [Related]
25. Hemophilia-associated AIDS in the United States, 1981 to September 1987. Stehr-Green JK; Holman RC; Jason JM; Evatt BL Am J Public Health; 1988 Apr; 78(4):439-42. PubMed ID: 3126675 [TBL] [Abstract][Full Text] [Related]
27. Prospective audit of patients with haemophilia: bleeding episodes and management. Alexander M; Barnes C; Barnett P J Paediatr Child Health; 2012 Feb; 48(2):177-9. PubMed ID: 21564382 [TBL] [Abstract][Full Text] [Related]
28. Haemophilia, the journey in search of a cure. 1960-2020. Nathwani AC; Tuddenham EGD Br J Haematol; 2020 Nov; 191(4):573-578. PubMed ID: 33190257 [TBL] [Abstract][Full Text] [Related]
29. Development and maintenance of hemophilia care program in Korea. Kim KY Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():52-60. PubMed ID: 7886608 [No Abstract] [Full Text] [Related]
30. Hemophilia with factor VIII and factor IX inhibitors, incidence, bleeding problems and management. Mahasandana C; Patharathienskul D; Suvatte V Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():106-12. PubMed ID: 7886549 [TBL] [Abstract][Full Text] [Related]
31. Protocols for the treatment of haemophilia and von Willebrand disease. Kasper CK; Haemophilia; 2000 Jul; 6 Suppl 1():84-93. PubMed ID: 10982273 [No Abstract] [Full Text] [Related]
32. The path to precision medicine for MS, from AI to patient recruitment: an interview with Mauricio Farez and Helen Onuorah. Commun Biol; 2021 Jul; 4(1):867. PubMed ID: 34294870 [TBL] [Abstract][Full Text] [Related]
33. How I manage patients with inherited haemophilia A and B and factor inhibitors. Ljung RCR Br J Haematol; 2018 Feb; 180(4):501-510. PubMed ID: 29270992 [TBL] [Abstract][Full Text] [Related]
36. Current challenges in the management of hemophilia. Bauer KA Am J Manag Care; 2015 Mar; 21(6 Suppl):S112-22. PubMed ID: 26168206 [TBL] [Abstract][Full Text] [Related]
37. Steps toward improved safety of treatment in hemophilia B. Goldsmith JC J Lab Clin Med; 1993 Mar; 121(3):370-1. PubMed ID: 8445281 [No Abstract] [Full Text] [Related]
38. Gastrointestinal bleeding in haemophilia. Forbes CD; Barr RD; Prentice CR; Douglas AS Q J Med; 1973 Jul; 42(167):503-11. PubMed ID: 4542260 [No Abstract] [Full Text] [Related]
39. [Hemophilia and the acquired immune deficiency syndrome (AIDS)]. Sjamsoedin-Visser EJ; Breederveld C; Sixma JJ Ned Tijdschr Geneeskd; 1983 Jun; 127(23):1008-9. PubMed ID: 6877397 [No Abstract] [Full Text] [Related]
40. The Last 50 years of Hemophilia Care: A Golden Era. Seth T Indian Pediatr; 2024 May; 61(5):489-493. PubMed ID: 38736226 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]